Vaidya Sane Ayurved Laboratories secures patent for herbal formulation

1 min read     Updated on 01 Jul 2026, 09:27 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Vaidya Sane Ayurved Laboratories has been granted Indian Patent No. 593487 for a method of preparation of herbal formulation. The patent, valid for 20 years from the filing date of 29 November 2019, was granted on 25 June 2026. This move strengthens the company's intellectual property portfolio and competitive positioning in the Ayurvedic sector.

powered bylight_fuzz_icon
44349081

*this image is generated using AI for illustrative purposes only.

Vaidya Sane Ayurved Laboratories has been granted Indian Patent No. 593487 for a method of preparation of herbal formulation, strengthening its intellectual property portfolio. The patent, granted by the Office of the Controller General of Patents, Designs and Trade Marks, Government of India, provides statutory protection for 20 years from the date of filing. This development reinforces the company's commitment to research and innovation in the Ayurvedic healthcare segment.

Patent Details

The patent application was filed on 29 November 2019 and formally granted on 25 June 2026. The intellectual property rights cover a specific method for preparing herbal formulations, offering the company exclusive control over the process.

Particulars Details
Patent Title Method of Preparation of Herbal Formulation
Patent Number 593487
Patent Application No. 201921049131
Date of Filing 29 November 2019
Date of Grant 25 June 2026
Patentee Vaidya Sane Ayurved Laboratories Limited

Strategic Implications

The grant of this patent is expected to support the long-term business strategy of Vaidya Sane Ayurved Laboratories by enhancing its competitive positioning in the healthcare and Ayurvedic products market. By securing proprietary rights to its formulation methods, the company aims to protect its innovations from replication and drive growth through differentiated product offerings.

Historical Stock Returns for Vaidya Sane Ayurved Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+2.05%+10.00%+3.14%-34.62%+12.01%+77.42%

How will this patent impact the company's revenue growth and market share in the Ayurvedic healthcare sector?

What are the plans for leveraging this patented method to develop new product lines or expand existing offerings?

How might competitors respond to this patent, and could it lead to increased innovation or legal challenges in the industry?

Vaidya Sane Ayurved Laboratories
View Company Insights
View All News
like19
dislike

Madhavbaug launches FoodRx to manage lifestyle disorders

1 min read     Updated on 29 May 2026, 12:55 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Vaidya Sane Ayurved Laboratories Limited (Madhavbaug) has introduced FoodRx, a food intervention system using traditional Indian nutrition to prevent and manage lifestyle disorders like diabetes and heart disease. Based on data from 10 lakh patients, the system focuses on high-protein and high-fibre diets in familiar formats.

powered bylight_fuzz_icon
41585117

*this image is generated using AI for illustrative purposes only.

Vaidya Sane Ayurved Laboratories Limited, operating as Madhavbaug, has launched FoodRx, a clinically designed food intervention system aimed at preventive healthcare and the management of lifestyle disorders such as diabetes, obesity, and heart disease. The initiative leverages high-protein and high-fibre traditional Indian nutrition to address the growing burden of non-communicable diseases in India. The company has treated over 10 lakh patients for these conditions over 18 years, utilizing this clinical dataset to inform the FoodRx protocols.

The FoodRx system is built on three pillars: high protein from the Indian pantry, high fibre, and traditional formats that require minimal preparation time. The program emphasizes foods like moong dal, horsegram, urad, sprouted legumes, sattu, and paneer to reduce insulin resistance and preserve lean muscle mass. Millets, oats, and pulses form the fibre core, proven to reduce HbA1c levels and improve lipid profiles.

Clinical Foundation and Expansion

Founded in 2006 by Dr. Rohit Madhav Sane, Madhavbaug has expanded from a single clinic in Khopoli, Maharashtra, to over 350 clinics and 4 hospitals across India. The company is listed on the National Stock Exchange of India. Dr. Sane established the organization following the loss of his father to a heart attack in 2004, integrating Ayurveda with modern medicine.

Key Features of FoodRx

Feature Description
Focus Preventive healthcare and lifestyle disorder management
Nutritional Base High-protein and high-fibre traditional Indian food
Target Conditions Diabetes, obesity, heart disease
Preparation Style Traditional formats ready in 10 minutes

The product is positioned for individuals at risk of metabolic disorders, such as pre-diabetics and borderline hypertensive patients, rather than those already suffering from advanced illness. Dr. Rohit Madhav Sane, Founder & MD, stated that the company has been reversing diseases for 25 years and FoodRx is an effort to ensure fewer people need reversal in the first place.

Historical Stock Returns for Vaidya Sane Ayurved Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+2.05%+10.00%+3.14%-34.62%+12.01%+77.42%

How will Madhavbaug leverage its clinical data from 10 lakh patients to refine FoodRx protocols for personalized nutrition?

What is the expected market penetration for FoodRx given the rising prevalence of lifestyle disorders in India?

How will the company scale production and distribution of FoodRx products to meet demand across its 350 clinics and beyond?

Vaidya Sane Ayurved Laboratories
View Company Insights
View All News
like20
dislike

More News on Vaidya Sane Ayurved Laboratories

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:+12.01%